The FDA has granted Abbott expanded premarket approval for use of its Absolute Pro stent in treating patients with narrowed iliac arteries. The catheter-delivered device, which has been on the U.S. market since 2008 as a biliary stent, is also being marketed in more than 80 other countries.
FDA OKs expanded use of Abbott's Absolute Pro stent
SmartBrief Job Listings for Health Care
|NGS Provider Enrollment Rep||
National Government Services - WellPoint
|Program Manager II||
Tufts Health Plan/Network Health
|Director, Medicare Advantage/Medicare Part D Focus||
|Director of Clinical Research||
Regenesis Biomedical, Inc.
|Assistant Vice President - Dental Director||